Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Reduction of renal superoxide dismutase in progressive diabetic nephropathy.
Authors
Fujita H, Fujishima H, Chida S, Takahashi K, Qi Z, Kanetsuna Y, Breyer MD,
Harris RC, Yamada Y, Takahashi T
Submitted By
Takamune Takahashi on 3/24/2010
Status
Published
Journal
Journal of the American Society of Nephrology : JASN
Year
2009
Date Published
6/1/2009
Volume : Pages
20(6) : 1303 - 1313
PubMed Reference
19470681
Abstract
Superoxide excess plays a central role in tissue damage that results from
diabetes, but the mechanisms of superoxide overproduction in diabetic
nephropathy (DN) are incompletely understood. In the present study, we
investigated the enzyme superoxide dismutase (SOD), a major defender against
superoxide, in the kidneys during the development of murine DN. We assessed SOD
activity and the expression of SOD isoforms in the kidneys of two diabetic mouse
models (C57BL/6-Akita and KK/Ta-Akita) that exhibit comparable levels of
hyperglycemia but different susceptibility to DN. We observed down-regulation of
cytosolic CuZn-SOD (SOD1) and extracellular CuZn-SOD (SOD3), but not
mitochondrial Mn-SOD (SOD2), in the kidney of KK/Ta-Akita mice which exhibit
progressive DN. In contrast, we did not detect a change in renal SOD expression
in DN-resistant C57BL/6-Akita mice. Consistent with these findings, there was a
significant reduction in total SOD activity in the kidney of KK/Ta-Akita mice
compared with C57BL/6-Akita mice. Finally, treatment of KK/Ta-Akita mice with a
SOD mimetic, tempol, ameliorated the nephropathic changes in KK/Ta-Akita mice
without altering the level of hyperglycemia. Collectively, these results
indicate that down-regulation of renal SOD1 and SOD3 may play a key role in the
pathogenesis of DN.
Investigators with authorship
Name
Institution
Matthew Breyer
Johnson & Johnson
Raymond Harris
Vanderbilt University
Takamune Takahashi
Vanderbilt University
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Genes
Symbol
Description
Sod1
superoxide dismutase 1, soluble
Sod2
superoxide dismutase 2, mitochondrial
Sod3
superoxide dismutase 3, extracellular
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!